Liquidia Corporation Reports Second Quarter 2024 Financial Results and Provides Corporate Update
MORRISVILLE, N.C., Aug. 07, 2024 (GLOBE NEWSWIRE) — Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, today reported financial results for the second quarter ended June 30, 2024. The… Read More »Liquidia Corporation Reports Second Quarter 2024 Financial Results and Provides Corporate Update